Andrew Spieldenner, PhD

Like many people, I got tested positive for COVID-19. It was surreal how many feelings popped up from my HIV experience.

After almost 20 years of sero-sorting, I am starting to meet HIV-negative guys who are on PrEP and/or know about viral suppression.

Big pharma - a trillion-dollar industry - holds the keys to accessible treatment. TRIPS has been used to limit global availability of meds

I recently started as Executive Director of MPact: Global Action for Gay Health & Rights. Why would I do that when I’m already tenured?

For many of us in the HIV community, we have learned to live with loss. In this current pandemic, what lessons can we share?

The HIV and LGBTQ communities still struggle with race and how to integrate racial justice into our movements.

The US People living with HIV Caucus has some words for the incoming Administration

2020 is ending. The year is nothing like we expected when we rang in the New Year. What next?

I’m anxious in 2020. Through a global pandemic, increased focus on racial justice in the US, and an election coming up. It’s a lot.

HIV surveillance technologies continue to develop at a rapid rate. How does this affect our HIV community?

It’s 2020 and people still want us to prove AIDS-related stigma exists. I’m tired.

From domestic HIV advocacy to global views: The relevance of the U.N. Joint Programme

People living with HIV networks recognize the importance of community building at HIV2020 in the HIV response.

While public health advocates are discussing the “End of AIDS,” I am unsure where we as people living with HIV fit.

When communities bring up concerns about research, can we expect researchers to listen and engage us? Or are we just widgets to study?

We talk about self-care a lot, but what do we mean? Putting up the “DO NOT DISTURB” sign on our lives as people living with HIV.

As we celebrate Pride, let’s be intentional and inclusive with gender identity. I want us to stand against the rise of transphobia.